alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2016260EN.01000501.xml

| 18.7.2016 | EN | Official Journal of the European Union | C 260/5 |
| --- | --- | --- | --- |

18.7.2016

EN

Official Journal of the European Union

C 260/5

---

Judgment of the Court (Second Chamber) of 26 May 2016 (request for a preliminary ruling from the First-tier Tribunal (Tax Chamber) — United Kingdom) — Bookit Ltd v Commissioners for Her Majesty’s Revenue and Customs

(Case C-607/14) (1)

1

((Reference for a preliminary ruling - Common system of value added tax - Directive 2006/112/EC - Exemption - Article 135(1)(d) - Transactions concerning payments and transfers - Meaning - Purchase of cinema tickets by telephone or via the Internet - Payment by debit card or credit card - ‘Card handling’ services))

(2016/C 260/06)

Language of the case: English

Referring court

Referring court

First-tier Tribunal (Tax Chamber)

Parties to the main proceedings

Parties to the main proceedings

Applicant: Bookit Ltd

Applicant:

Defendant: Commissioners for Her Majesty’s Revenue and Customs

Defendant:

Operative part of the judgment

Operative part of the judgment

Article 135(1)(d) of Council Directive 2006/112/EC of 28 November 2006 on the common system of value added tax must be interpreted as meaning that the exemption from value added tax provided for therein for transactions concerning payments and transfers is not applicable to a ‘card handling’ service, such as that at issue in the main proceedings, supplied by a taxable person, the provider of that service, where an individual purchases, via that service provider, a cinema ticket which the service provider sells for and on behalf of another entity, and which the individual pays for by debit card or by credit card.

---

(1)  OJ C 81, 9.3.2015.

1

---
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                       0
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      2,791
<COMMON>                                         3,485
<OTHER-SE>                                     (6,276)
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 8,687
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (8,687)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                961,841
<CHANGES>                                            0
<NET-INCOME>                                   953,154
<EPS-BASIC>                                       3.37
<EPS-DILUTED>                                     3.37


</TABLE>
Exhibit
31.2




Certification
of Chief Financial Officer


Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002







I, Shawn
A. Callahan, Chief Financial Officer, certify that:





1.    I
have reviewed this Annual Report on Form 10-K of Metwood, Inc. and
subsidiary  (the “Company”).





2.    Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statement made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this report;





3.    Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects, the financial
condition, results of operations and cash flows of the Company as of, and for,
the periods presented in this report;





4.    The
Company’s other certifying officer(s) and I am responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15d-15(e) and 15d-15(e)) for the Company and have:





(a)    Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the Company, including its consolidates subsidiaries, is
made known to us by others within those entities, particularly during the period
in which this report is being prepared;





(b)    Evaluated
the effectiveness of the Company’s disclosure controls and procedures, and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and





(c)    Disclosed
in this report any change in the Company’s internal control over financial
reporting that occurred during the Company’s fourth fiscal quarter that has
materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting; and





5.    The
Company’s other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the Company’s
auditors and the audit committee of Company’s board of directors (or persons
performing the equivalent functions):





(a)    All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to
adversely affect the Company’s ability to record, process, summarize and report
financial information; and





(b)    Any
fraud, whether or not material, that involves management or other employees who
have a significant role in the Company’s internal control over financial
reporting.




Date: October
      14, 2008
            By:
            /s/ Shawn
      A. CallahanShawn
      A. Callahan
              Chief Financial
      Officer
### Exhibit 32.2

### 

### CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of American Community Properties Trust (the "Company") on Form 10-Q for the period ending September 30, 2003, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Cynthia L. Hedrick, Chief Financial Officer of the Company, certify to my knowledge, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that:



1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.









|/s/ Cynthia L. Hedrick 
|-----------------------
|Cynthia L. Hedrick     
|Chief Financial Officer
|November 12, 2003
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM LUDLUM
CONSTRUCTION CO., INC. FORM 10-QSB FOR THE THREE MONTHS ENDED MARCH 31, 2000 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                          58,574
<SECURITIES>                                         0
<RECEIVABLES>                                  289,532
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               554,615
<PP&E>                                       3,935,565
<DEPRECIATION>                               1,800,590
<TOTAL-ASSETS>                               2,733,091
<CURRENT-LIABILITIES>                        1,951,307
<BONDS>                                        651,703
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        37,110
<OTHER-SE>                                      92,971
<TOTAL-LIABILITY-AND-EQUITY>                 2,733,091
<SALES>                                        672,877
<TOTAL-REVENUES>                               673,168
<CGS>                                          486,302
<TOTAL-COSTS>                                  635,554
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              55,518
<INCOME-PRETAX>                                (17,904)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (17,904)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (17,904)
<EPS-BASIC>                                      (.005)
<EPS-DILUTED>                                    (.005)


</TABLE>
No. 12-8362.

#### Baggett v. Illinois.

App. Ct. Ill., 1st Dist. Certiorari denied.
<PAGE>
                                                                    EXHIBIT 23.2

                         CONSENT OF INDEPENDENT AUDITORS

We consent to the incorporation by reference in the registration statements on
Form S-8 (Nos. 2-76455, 33-50528, 333-20843, 333-32425, 333-35842, 333-86973 and
333-74770) and Form S-3 (Nos. 333-61796 and 333-87160) of EMS Technologies, Inc.
of our report dated February 6, 2004 with respect to the consolidated financial
statements of EMS Technologies Canada, Ltd. incorporated by reference in this
Annual Report (Form 10-K) of EMS Technologies, Inc. for the year ended December
31, 2003.


March 28, 2005                         Ernst & Young LLP
Ottawa, Canada                         Chartered Accountants
Exhibit
32.2













CERTIFICATION
PURSUANT TO






SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002










In
connection with the Quarterly Report of American Community Properties Trust (the
“Company”) on Form 10-Q for the period ending March 31, 2009, as filed with the
Securities and Exchange Commission on the date hereof (the “Report”), I, Matthew
M. Martin, Chief Financial Officer of the Company, certify to my knowledge,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section
1350), that:








1.
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and


2.
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.














By: /s/ Matthew M.
MartinMatthew
      M. MartinChief
      Financial OfficerMay
      21,
2009
U.S. Depa

rtment of 

Health and Human Services 

- Centers for Disease 

Control and Prevention 

CDC .gov/tips
# Pearl Harbor’s Santiago awarded Commander’s Mission Impact Award

/ Published Jan. 29, 2016
PEARL HARBOR, Hawaii, 
Eric Santiago, accountable property officer at Defense Logistics Agency Distribution Pearl Harbor, Hawaii, has been awarded the Commander’s Mission Impact Award for first quarter fiscal year 2016.
“Mr. Santiago’s resourcefulness, attention to detail and ability to plan, program, and accurately manage accountable property has proven invaluable to Distribution’s ability to support the Pacific warfighters,” said Thomas Dillon, DLA Distribution Pearl Harbor deputy commander.

Santiago is responsible for the management of DLA Distribution Pearl Harbor’s $12.7 million account, providing cradle-to-grave accountability, and technical oversight of capital and non-capital assets supporting 175 employees in 22 geographically-separated facilities.  “Within three months of assuming APO responsibilities, Mr. Santiago reinvigorated the program, synchronizing property and production requirements as well as capturing future mission changes,” said Dillon.  

As part of his duties, Santiago trained eight newly-assigned hand receipt holders and segregated accounts into appropriate business segments.  Additionally, he conducted a 100 percent floor-to-book inventory, providing accurate capital and non-capital lifecycle forecasting.  As a result of Santiago’s positive program oversight, he was appointed as Distribution's APO liaison for the Pacific region.

In addition to his significant APO responsibilities, Santiago assumed oversight of two equipment maintenance contracts valued at $500,000, which includes contracting officer's representative duties and commensurate training.  He took direct control of fleet management and dispatch duties, ensuring fleet rotation and enhanced utilization.  Santiago was responsible for analyzing and preparing the distribution center’s non-capital vehicle requirements and resolving resource gaps in warehouse conveyance.  

“Mr. Santiago not only demonstrates flawless performance as an APO, but also an unparalleled dedication,” said Dillon.  “His selflessness is a primary reason DLA Distribution Pearl Harbor is able to accomplish the mission!”
No. 10-7591.

#### James A. Childs, Petitioner v. James Olson, et al.

562 U.S. 1175, 131 S. Ct. 1016,

178 L. Ed. 2d 822,

2011 U.S. LEXIS 703.

January 18, 2011.

Motion of petitioner for leave to proceed in forma pauperis denied, and petition for writ of certiorari to the United States Court of Appeals for the Tenth Circuit dismissed. See Rule 39.8. As petitioner has repeatedly abused this Court’s process, the Clerk is directed not to accept any further petitions in noncriminal matters from petitioner unless the docketing fee required by Rule 38(a) is paid and petition submitted in compliance with Rule 33.1. See Martin v. District of Columbia Court of Appeals, 506 U.S. 1, 113 S. Ct. 397, 121 L. Ed. 2d 305 (1992) (per curiam).
____________________ County: 

_________ Country: 

_____________________________________________________________________ 

_____________________________________________________________________ 

_____________________________________________________________________ 

_____________________________________________________________________ 

_____________________________________________________________________ 

_____________________________________________________________________ 

_____________________________________________________________________ 

_____________________________________________________________________ 

_____________________________________________________________________ 

_____________________________________________________________________ 

Respiratory Outbreak Survey 

1. Date of contact: ___ / ___ / ______ 

2. Contact person: Name: _____________________________ 

Affiliation: _____________________________ 

_____________________________ 

_____________________________ 

Phone: 

E-mail:

3. Site of Outbreak: City: _____________ 

State: _______________________ 

4. Outbreak setting: (Circle all that apply) 

Community Institution Military Other: ___________________ 

5. Persons Ill: 

Number of cases: ______ 

______ 

______ 

Hospitalizations: 

Deaths: 

Date first person became ill: __/__/____ 

Date most recent person became ill: __/__/____ 

Ages: (Circle all that apply) Children Adults Elderly

High risk population (e.g. HIV+, transplant patients): __________________________ 

6. Denominator Data: (If available) 

Total persons within outbreak setting: _______________________ 

7. Clinical Presentation: (Predominant syndrome, signs & symptoms) 

8. Radiographic Findings: (Chest x-rays performed, predominant findings) 

9. Diagnostic Laboratory Testing: (Pending and completed, available specimens) 

10. Differential diagnosis: (Specific pathogen suspected, others considered) 

11. Notes:
##### 



Exhibit 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002 I, Philip A. Garcia, certify that:  1.
    
    I have reviewed this annual report on Form 10-K/A of Erie
Family Life Insurance Company for the year ended December 31,
2003;2.
    
    Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading
with respect to the period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in
all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the
periods presented in this report;4.
    
    The registrants other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:  a.
    
    Designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material
information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in
which this report is being prepared;b.
    
    Evaluated the effectiveness of the registrants
disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; andc.
    
    Disclosed in this report any change in the
registrants internal control over financial reporting that
occurred during the registrants most recent fiscal quarter
that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over
financial reporting; and  5.
    
    The registrants other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over
financial reporting, to the registrants auditors and the audit
committee of registrants board of directors:  a.
    
    All significant deficiencies and material
weaknesses in the design or operation of internal control
over financial reporting, which are reasonably likely to
adversely affect the registrants ability to record,
process, summarize and report financial information; andb.
    
    Any fraud, whether or not material, that involves
management or other employees who have a significant role in
the registrants internal control over financial reporting. Date: March 31, 2004 /s/ Philip A. Garcia

Philip A. Garcia, Executive Vice President & CFO
 63
#### *State, Respondent, v. Brown, Petitioner,*

No. 92141-5.

Petition for review of a decision of the Court of Appeals, No. 70148-7-I, July 27, 2015, 189 Wn. App. 1002. *Denied*January 6, 2016.
[Federal Register Volume 63, Number 130 (Wednesday, July 8, 1998)]
[Notices]
[Page 36929]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-18134]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Microbiological and Immunological Sciences 
Special Emphasis Panel.
    Date: July 16, 1998.
    Time: 2:00 pm to 4:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Gerald Liddell, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4186, MSC 7808, Bethesda, MD 
20892, 301-435-1150.

    Name of Committee: Microbiological and Immunological Sciences 
Special Emphasis Panel.
    Date: July 22, 1998.
    Time: 12:00 pm to 2:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Gerald Liddel, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4186, MSC 7808, Bethesda, MD 
20892, 301-435-1150.

    Name of Committee: Clinical Sciences Special Emphasis Panel.
    Date: July 28, 1998.
    Time: 11:00 am to 1:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Gordon L. Johnson PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4136, MSC 7802, Bethesda, MD 
20892, 301-435-1212.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine, 93.306; 93.333, Clinical Research, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 29, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-18134 Filed 7-7-98; 8:45 am]
BILLING CODE 4140-01-M
No. 10-203.

#### Thomas J. Cahill, et al., Petitioners v. James L. Alexander, et al.

562 U.S. 1123, 131 S. Ct. 820,

178 L. Ed. 2d 579,

2010 U.S. LEXIS 9812.

December 13, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.

Justice Sotomayor took no part in the consideration or decision of this petition.

Same case below, 598 F.3d 79.